Join
Live feed
·
INSIDERFilingvia Quantisnow
Ocular Therapeutix Inc. logo

Chief Development Officer Kaiser Peter sold $20,672 worth of shares (3,009 units at $6.87), decreasing direct ownership by 1% to 210,078 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
OCUL· Ocular Therapeutix Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCUL (Ocular Therapeutix Inc.) and more on Quantisnow.